Arthritis Research & Therapy

official impact factor 4.36

Open Access

Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2

Evangelia S Lourida, Athanasios N Georgiadis, Eleni C Papavasiliou, Athanasios I Papathanasiou, Alexandros A Drosos and Alexandros D Tselepis*

Arthritis Research & Therapy 2007, 9:R19 doi:10.1186/ar2129

Accesses  

  • Last 30 days: 62 accesses
  • Last year: 553 accesses
  • All time: 3950 accesses

Cited by

BioMed Central: 1 citation

Research article   Open Access Highly Accessed

Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study

Antonio Naranjo, Tuulikki Sokka, Miguel A Descalzo, Jaime Calvo-Alén, Kim Hørslev-Petersen, Reijo K Luukkainen, Bernard Combe, Gerd R Burmester, Joe Devlin, Gianfranco Ferraccioli, Alessia Morelli, Monique Hoekstra, Maria Majdan, Stefan Sadkiewicz, Miguel Belmonte, Ann-Carin Holmqvist, Ernest Choy, Recep Tunc, Aleksander Dimic, Martin Bergman, Sergio Toloza, Theodore Pincus, Arthritis Research & Therapy 2008, 10:R30 (6 March 2008)

Treating rheumatoid arthritis with disease-modifying anti-rheumatic drugs, such as methotrexate, reduces the risk of heart attacks and strokes, data from a study of 4,363 patients across 15 countries shows.